Latest Breaking News On - மேப்பிள் சிரப் சிறுநீர் - Page 4 : comparemela.com

EQS-News: Relief Therapeutics Announces CHF 15 Million Private Placement vom 26.07.2021, 07:00 Uhr Bild: pixabay.com Relief Therapeutics Announces CHF 15 Million Private Placement 26.07.2021 / 07:00   Relief or the Company ), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced that it has entered into a definitive agreement with two U.S. institutional investors to purchase in a private placement an aggregate of 71,428,572 shares of Relief common stock at a purchase price of CHF 0.21 per share. The aggregate gross proceeds from the private placement are expected to be approximately CHF 15 million, before deducting the placement agent fees and offering expenses payable by Relief. The private placement offering is expected to close on or about July 28, 2021, subject to the satisfaction of customary closing conditions.

United statesAnne henneckeJack weinsteinAdvita lifescience gmbMc servicesPharma researchSwiss exchangeHoldings ag keyHc wainwright coAcer therapeutics incGroup news servicePrivate placementChief financial officerAdvita lifescience gmbhUnited states securities actVasoactive intestinal peptide